AstraZeneca Pharma P/B Ratio

Current P/B Ratio
17.54
High Valuation
Very High - Significant premium, high growth expectations or speculative

AstraZeneca Pharma P/B ratio. AstraZeneca Pharma (ASTRAZEN) P/B ratio is 17.54 (High), book value per share ₹1746.00 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse ASTRAZEN income statement for revenue, profit, balance sheet and cash flow data.

Current Valuation Metrics

P/B Ratio 17.54
Current Price ₹6113.00
Book Value/Share ₹1746.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹873 Cr
Share Capital ₹5 Cr
Reserves & Surplus ₹868 Cr
Outstanding Shares 5,000,000
Book Value per Share ₹1746.00

Valuation Signal

Signal Overvalued
Historical Avg 4.48
Historical Range 3.23 - 5.86
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

ASTRAZEN P/B Ratio — Valuation Insights & Book Value Analysis

AstraZeneca Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 17.54 (High). For live price, earnings yield and the full fundamental profile, see AstraZeneca Pharma share price today.

  • Stock appears overvalued with PB of 17.54, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 291.3% above historical average
  • Trading at premium to sector average PB of -0.3

AstraZeneca Pharma P/B Ratio Historical Trend

ASTRAZEN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read ASTRAZEN dividend growth for the complete payout history and dividend yield track record.

ASTRAZEN Historical P/B Ratio — Book Value Per Share & Year-End Price

AstraZeneca Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 3.5 ₹1746.0 ₹6113.00 ₹873 High
2025 5.86 ₹1540.0 ₹9029.00 ₹770 High
2024 5.13 ₹1424.0 ₹7305.15 ₹712 High
2023 4.69 ₹1178.0 ₹5526.60 ₹589 High
2022 3.23 ₹1022.0 ₹3297.15 ₹511 High

ASTRAZEN vs Healthcare Peers — P/B Ratio Comparison

AstraZeneca Pharma P/B 17.54 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low